Combination of HPLC-Q-TOF-MS/MS, Network Pharmacology, and Molecular Docking to Reveal the Mechanism of Apple Pollen in the Treatment of Type 2 Diabetes Mellitus

Wang, Yiwen; Chen, Ping

doi:https://doi.org/10.1155/2022/3221196

Evidence-Based Complementary and Alternative Medicine

On this page

Abstract Introduction Materials and Methods Results and Discussion Discussion Conclusions Data Availability Conflicts of Interest Acknowledgments References Copyright Related Articles

Research Article | Open Access

Volume 2022 | Article ID 3221196 | https://doi.org/10.1155/2022/3221196

Combination of HPLC-Q-TOF-MS/MS, Network Pharmacology, and Molecular Docking to Reveal the Mechanism of Apple Pollen in the Treatment of Type 2 Diabetes Mellitus

Yiwen Wang¹and Ping Chen^1,2

Academic Editor: M. Maulidiani

Received16 Jun 2021

Revised01 Jan 2022

Accepted03 Jan 2022

Published24 May 2022

Abstract

Studies have found that apple pollen can restrain the activity of amylase. Therefore, we speculate that it may be prescribed to treat patients with type 2 diabetes mellitus (T2DM), while its chemical and pharmacologic profiles remain to be further explained. In this study, the potential bioactive compounds of apple pollen and the underlying mechanism of action were investigated by performing chemical and network pharmacology analysis. Therefore, HPLC-QTOF-MS/MS analysis based on chemical compound libraries was applied in identifying the chemical profiles of apple pollen and network pharmacology was adopted for predicting the potential targets of the active components of apple pollen. Initially, the chemical map of apple pollen was identified and characterized. Secondly, the potential targets of active compounds of apple pollen were predicted with the Swiss Target Prediction and PharmMapper databases, whereas targets of T2DM were collected from the GeneCards and OMIM database. Thereafter, the target of active compounds and T2DM targets established common targets using Venn. Afterwards, the common targets were imported into the STRING database in order to construct the protein-protein interaction (PPI) network and select the core targets of apple pollen treatment of T2DM. In addition, GO and KEGG signaling pathway enrichment analyses were conducted on the selected core targets using the DAVID database. As a result, totally 28 compounds were identified. Meanwhile, network pharmacological analysis showed that 3-hydroxy-3-methyl glutaric acid, 5-hydroxyindoleacetic acid, DL-3-phenyllactic acid, isorhamnetin-3-glucoside-4′-glucoside, isorhamnetin-3-O-glucoside, syringetin-3-O-galactoside, rhamnetin, m-coumaric acid, quercitrin, isorhamnetin-3-galactoside-6″-rhamnoside, and kaempferol-3-O-alpha-L-arabinoside might be the active compounds of apple pollen. Moreover, AKT1, PPARG, SRC, EGFR, CASP3, ESR1, and the other potential core targets might be involved in the treatment of T2DM by modulating the following pathways, containing insulin resistance, hepatitis C, pancreatic cancer, insulin signaling pathway, TNF signaling pathway, and PI3K-AKT signaling pathway. Quercitrin, kaempferol, and isorhamnetin-3-O-glucoside bound most stably to AKT1. Isorhamnetin-3-O-glucoside and quercitrin bound most stably to SRC. In addition, arachidonic acid bound most stably to PPARG.

1. Introduction

Type 2 diabetes mellitus (T2DM) is the main subtype of diabetes mellitus (DM), with insulin resistance (IR) being the main pathological feature. T2DM is characterized by the disorders of glucose metabolism, glucose metabolism-related enzymes, and lipid metabolism. The main complications include cardiovascular disease (CVD), renal failure (RF), peripheral neuropathy, and obesity, causing serious health damage and economic burdens on the patients [1, 2]. At present, insulin and its analogues such as sulfonylureas and glinides are the main drugs used to treat T2DM [3]. However, these drugs will cause a variety of side effects such as cardiotoxicity and psychotoxicity. Therefore, it is of necessity to explore the safe and effective anti-T2DM drugs for the clinical application.

Pollen is a kind of natural advanced nutrition worthy of development and research, not only rich in amino acids, vitamins, nucleic acids, flavonoids, unsaturated fatty acids, protein active enzymes [4], etc., but also in a reasonable ratio [5]. Due to its good cosmetic effect, it is called “edible cosmetics” by women [6–10]. In addition, it has an extremely important role in preventing human aging, promoting metabolism, and regulating human functions [11]. Apple pollen (Malus pumila Mill.) is a kind of apple pollen powder, which is extensively distributed throughout China and is usually collected from April to May in spring. Apple pollen has been reported to possess extensive pharmacological activities [12–15], such as preventing myocardial infarction (MI), strengthening the immune system, preventing aging, treating CVDs, inhibiting tumor, and protecting the liver [6]. Some scholars [10] performed comparative tests on the effects of various pollen on enhancing immune function, including body weight, thymus and spleen weight, lymphocyte transformation, macrophage phagocytosis test, NK cell activity, peripheral blood IgG, spleen plaque hemolysis test, lactate dehydrogenase, and arginase of peritoneal macrophages. Clinical evidence demonstrates that pollen is effective in improving human immune function. Consequently, it has a favorable clinical application and development prospect [16]. Additionally, studies have also shown that pollen can lower intestinal absorption of cholesterol, increase excretion, inhibit the proliferation of high-fat aortic smooth muscle cells, show its SMC proliferation, and exert an important role in reducing plaque formation, as well as regulating the metabolism of prostacyclin and thromboxane AZ. It also shows that it can regulate the transformation of prostaglandin metabolic enzymes as well as the absorption and excretion of cholesterol. Pollen can inhibit platelet aggregation, improve blood fluidity, activate the function of monocyte macrophages, and protect cell intima, also preventing fibrin damage and other systemic pharmacological effects. Clinically, it generates a good effect on cardiovascular diseases [9]. The main chemical components of apple pollen [17, 18] include flavonoids, organic acids, polysaccharides, amino acids, vitamins, and mineral elements. In the present study, two major varieties of apple pollen (Qinguan and Gala pollen) were selected as the objects due to their extensive source, high yield, and good taste.

High performance liquid chromatography coupled with electrospray ionization and quadrupole time-of-flight-mass spectrometry (HPLC-Q-TOF-MS/MS) is a powerful and reliable analytical technique developed to identify natural products [19], which is ascribed to its advantages of efficient separation ability of HPLC and highly sensitive detection of MS [20]. Till the present, HPLC-Q-TOF-MS/MS has never been reported for the identification and comparison of chemical compositions in Qinguan and Gala pollen. Therefore, this study mainly aimed to develop a rapid and effective method for the identification and comparison of major components in apple pollen based on the HPLC-QTOF-MS/MS technique. Then, the quality markers of apple pollen for treating T2DM are further selected from the detected components by network pharmacology. Based on the obtained findings, active constituent and the mechanism of action of apple pollen for treating T2DM will be revealed. The design of this experiment is displayed in Figure 1.

2. Materials and Methods

2.1. Materials

The Agilent 1200 HPLC system interfaced with Agilent 6520 hybrid quadrupole time of flight mass spectrometer (Agilent Technologies, USA) was utilized in this study. The system was operated under the control of MassHunter Acquisition software (version B.04.00).

Both methanol and formic acid (LC-MS grade) were purchased from Fisher Scientific (Leicestershire, UK), purified water was provided by Hangzhou Wahaha Group (Hangzhou, China), and ethanol (AR grade) was obtained from Tianjin Tianli Chemical Reagents Ltd. (Tianjin, China).

Qinguan pollen (batch number: 20140410) and Gala pollen (batch number: 20140401) were obtained from apple demonstration areas in the Northwest Agriculture and Forestry University (Baishui, Shaanxi Province; Lingbao, Henan Province).

2.2. HPLC-QTOF-MS/MS Analyses

2.2.1. HPLC and MS Conditions

Chromatographic separation was performed using a Boston Green ODS-C18 column (4.6 × 250 mm, 5 μm). The mobile phase consisted of A (0.1% formic acid in water) and B (0.1% formic acid in methanol). The following gradient program was adopted for separation: 0∼15 min, 10%∼20%; 15∼45 min, 20%∼40% B; 45∼75 min, 40%∼80% B; 75∼80 min, 80%∼90% B; and 80∼85 min, 90%∼100% B. The injection volume was 10 μL, the column temperature was set at 25°C, and the solvent flow rate was set at 0.8 mL·min⁻¹.

Mass spectrometer was operated in the negative electrospray ionization mode, and spectra were recorded by scanning the mass range from m/z 50 to 1100. The flow rate of drying gas (N2) was set at 8 L/min. Meanwhile, the heated capillary temperature was set at 350°C and the nebulizer pressure was set at 35 psi. Besides, the source parameter capillary voltage was set at 3500 V, the fragmenting voltage was 135 V, and the split ratio was 1 : 3. The collision energy for MS/MS analysis was tested within the range of 20–40 eV [21].

2.2.2. Sample Preparation

Approximately 1.0 g of each sample (Qinguan pollen and Gala pollen) was accurately weighed and put into a capped 100 mL conical flask. Thereafter, each respective sample was extracted with 50 mL ethanol by reflux extraction for 1 h. Then, the extract was filtered and dried, while the residue was reconstituted with 50 mL methanol and filtered through a 0.25 μm membrane filter before the injection into the HPLC system. The sample injection volume was 10 µL.

2.2.3. Identification of Compounds

The accurate mass data of molecular ions were processed by adopting the Mass Hunter Acquisition software (version B.04.00). The obtained parent ion information and a large number of daughter ion fragments were analyzed by MassHunter software. The molecular formula and molecular weight were deduced by the “molecular search function” and matched with the MassBank standard spectrum to deduce the chemical structure and determine the final structure of the compound. The total ion chromatograms of Qinguan and Gala apple pollen obtained are illustrated in Figure 1.

2.3. Network Pharmacology

2.3.1. Target Prediction

Initially, the canonical SMILES information of each identified compounds was obtained by the NCBI PubChem database (https://www.ncbi.nlm.nih.gov/pubmed/) and then uploaded into the SwissTargetPrediction database (https://www.swisstargetprediction.ch/) [9] and PharmMapper (https://www.lilab-ecust.cn/pharmmapper/). Obviously, the species was limited to “Homo sapiens” for target prediction and the minimum interaction threshold was set to “highest possible” >0.6 by comparing with the known active compounds. Secondly, T2DM-related targets were obtained from the DrugBank database (https://go.drugbank.com) and GeneCards database (https://www.genecards.org/) based on the key word search of “Type 2 Diabetes Mellitus.” Besides, the duplicate targets were eliminated.

2.3.2. Construction of the Target Protein-Protein Interaction (PPI) Network

The PPI network was constructed based on the STRING database (https://string-db.org/) by incorporating the overlapping targets between the candidate compound targets and the T2DM-related targets.

2.3.3. Gene Ontology (GO) Functional Annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) Pathway Enrichment Analyses

GO functional annotation and KEGG pathway enrichment analyses of the common target genes were conducted using the DAVID database platform (https://david.ncifcrf.gov) [22, 23]. The results were presented with online analysis as a bar chart and bubble chart, respectively.

2.3.4. Molecular Docking

The core component target and ligand files were retrieved from the chemical database (Pub Chem) and the protein database (RCSB-Pdb). The Autodock Vina software was adopted for molecular docking of the core component target.

2.3.5. Construction of the Active Component-Common Target Gene Pathway Network

The pharmacological network of “chemicals-targets-pathways” was constructed to screen the potential chemical components related to the therapeutic effects on T2DM (Figure 1). The active component-disease-target gene pathway interaction network was constructed by the Cytoscape 3.7.1 software.

3. Results and Discussion

3.1. Chemical Profiles of Apple Pollen Detected by UHPLC-Q/TQF-MS

The monitoring ion for detection and analysis is shown in Figure 2. In the current work, altogether 32 components from Qinguan pollen and Gala pollen were characterized by UHPLC-Q/TOF-MS analysis (Tables 1 and 2).

(a)

(b)

A total of 28 compounds were identified, which mainly included flavonoids and organic acids (Tables 1 and 2). Among them, 17 compounds were identified and characterized for the first time in apple pollen, including malvidin, glucuronic acid, N,N-dimethyl-N′-phenylsulfamide, amobarbital, 3-hydroxy-3-methyl glutaric acid, 7-methylguanine, 5-hydroxyin doleacetic acid, L-tryptophan, coumarinic acid-β-D-glucoside, quercitrin, rhamnetin, m-coumaric acid, DL-3-phenyllacticacid, isorhamnetin-3-glucoside-4′-glucoside, isorhamnetin-3-O-glucoside, syringetin-3-O-galactoside, isorhamnetin-3-galactoside-6″-rhamnoside, and kaempferol-3-O-alpha-L-arabinoside [18, 24, 25].

3.2. Absorption Parameters of Components

Based on a computer prediction method to calculate the identified compounds of apple pollen, this study obtained absorption parameters that could determine whether the chemical compositions could be absorbed. Table 3 showed the specific absorption parameters of all of the components [26]. The data indicated that there were a total of 18 chemical compositions (Figures 3 and 4) that satisfied the principles of drug absorption (GI absorption is high and at least two of the five Druglikeness were yes). Although the relative molecular masses of those compounds were greater than 500, we could import these glycosides’ aglycones into PharmMapper in order to obtain the relevant parameters. According to the results, both of these components were consistent with the five principles of drug absorption, and thus we considered that these 7 chemical compositions could be absorbed in the body.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

3.3. Screening of Chemical Ingredient Targets in Apple Pollen for Treating T2DM

By employing Swiss Target Prediction and PharmMapper, a total of 196 targets were predicted. Additionally, totally 961 T2DM target genes were uncovered in the GeneCards database and OMIM database. Later, the above genes were intersected in the Venny, and 196 target genes for Apple pollen for T2DM were obtained (Figure 5). At the same time, 61 targets were also acquired after intersection.

3.4. Construction and Analysis of the Target PPI Network

After comparatively analyzing 28 component targets and T2DM disease targets, 37 common potential targets were identified for apple pollen. The STRING database is a commonly used tool to predict PPI and produce the integrated and objective association networks. With the common protein targets as the input for network visualization, a diversified PPI network was created, which systematically summarized the interactions of apple pollen targets associated with T2DM treatment (Figure 6(a)). The hub protein was obtained by using CytoHubba plug-in. See Figure 6(b). The 10 hub proteins were AKT1, EGFR, SRC, PPARG, ESR1, CASP3, Mapk14, mapk1, NOS3, and ace from large to small.

(a)

(b)

3.5. Screening of Key Pathways in Apple Pollen for Treating T2DM

Thereafter, the drug-disease intersection genes were introduced into the DAVID database. Then, the target gene name list was input, the species was limited to “Homo sapiens,” the target gene name was modified to official gene symbol, and the threshold was set at . Thereafter, GO functional annotation and KEGG pathway enrichment analyses were performed.

GO analysis of the common targets revealed that the biological process (BP) was mainly related to negative regulation of apoptotic process, signal transduction, steroid hormone mediated signaling pathway, peptidyl-serine phosphorylation, transcription initiation from RNA polymerase II promoter, positive regulation of transcription from RNA polymerase II promoter, and cellular response to insulin stimulus (Figure 7(a)).

(a)

(b)

KEGG pathway enrichment analysis of the aforementioned common target genes is presented in Figure 7(b).

3.6. Active Component-Target-Gene-Pathway Interaction Network

The network diagram of “Active Component Target-Gene-Pathway” was constructed in Cytoscape software (Figure 8). According to the analysis results, the network consisted of 54 nodes and 160 edges in total, and each chemical acted on multiple T2DM targets, reflecting the “multicomponent and multitarget” mechanism in the treatment of T2DM. Specifically, the square, circular, and diamond nodes represent targets, apple pollen components, and pathways, respectively, and each node size was proportional to its degree.

3.7. Molecular Docking Verification

The core components arachidonic acid, quercitrin, isorhamnetin-3-O-glucoside, and kaempferol were molecularly docked with the core targets AKT1, PPARG, and SRC and when the binding bond energy was <−5 kcal/mol, indicating good docking results for both. The molecular docking model was plotted using PyMOL [27] (Figure 9).

(a)

(b)

(c)

(d)

(e)

(f)

4. Discussion

Over the past 30 years, the number of DM cases in China has increased significantly. Among them, T2DM accounts for 97.3%, whereas type 1 diabetes mellitus (T1DM) takes up nearly 5%, and other types account for only 0.7% [4]. T2MD is a chronic metabolic disease, which can also generate a variety of complications, such as diabetic nephropathy, diabetic foot, diabetic encephalopathy, and even physical disability or death. Its etiology is complex and its pathogenesis remains to be further elucidated. At present, insulin resistance, inflammatory cytokines, and DNA methylation are mostly considered to be associated with its etiology. We have experimentally confirmed that the alcoholic and aqueous extracts of apple pollen exert an inhibitory effect on α-amylase. Therefore, we predict that apple pollen generates a therapeutic effect on T2DM.

The HPLC-Q-TOF-MS/MS technique [28] helped to identify the chemical compositions in two kinds of apple pollen accurately and rapidly. At first, we employ the separation system and the physical and chemical identification methods. A previous study in apple pollen has tentatively confirmed the main chemical classes, such as flavonoid glycosides and organic acids [29]. The carboxyl and phenolic hydroxyl of organic acid molecules can easily form stable oxygen anion, while mass spectrometry in negative electrospray ionization mode allows obtaining more information than that in the positive mode. With better peak response in negative mode than that in positive mode, flavonoid glycoside compounds have relatively large polarity [30]. Therefore, this study chose negative electrospray ionization mode. We successfully identified a total of 26 compounds in Qinguan pollen and Gala apple pollen using HPLC-Q-TOF-MS/MS technique. According to the obtained results, the selected components of apple pollen showed a high binding activity, which might be used as the potential target genes of apple pollen for treating T2DM. These constituents primarily included arachidonic acid, quercitrin, kaempferol, and isorhamnetin-3-O-glucoside.

In addition to active ingredients, we also successfully predicted drug targets of apple pollen. The major targets included AKT1, PPARC, EGFR, and SRC. AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2, and AKT3) called the AKT kinase, regulating numerous processes including metabolism, proliferation, cell survival, growth, and angiogenesis. AKT is responsible for the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface (by similarity) [30]. PPARG binds nuclear receptor for peroxisome proliferators, such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. As a result, it controls the peroxisomal beta-oxidation pathway of fatty acids. PPARG is the key regulator of adipocyte differentiation and glucose homeostasis [31].

Analysis of KEGG enrichment pathways identified totally 17 pathways that are closely related to the development of T2DM. Meanwhile, the relationship between several of these pathways and T2DM and its complications has been verified by experimental or clinical studies. For example, patients with hepatitis B or C are more likely to develop diabetes, and the possible mechanism lies in the fact that hepatitis B virus infection can lead to abnormal liver metabolism. Consequently, insulin resistance and hepatitis B virus can lead to hepatic glucose metabolism by impairing liver function and hepatitis B virus can cause abnormal liver glucose metabolism by impairing liver function [32]. Besides, hepatitis C virus can affect insulin signaling, influence lipid metabolism, and damage islet cells, thus contributing to the development of diabetes [33]; HIF-α is closely related to the development of diabetes and its complications [34]. A large amount of HIF-α will accumulate in cells under high glucose hypoxia, aggravating the ischemic-hypoxic state of diabetic patients and promoting the development of diabetes. TNF can induce apoptosis by promoting the release of inflammatory factors [35], and TNF-α is closely related to insulin resistance [36]. The mechanism may be associated with TNF-α inhibiting insulin signaling by activating the NF-κB signaling pathway [37]. In addition, serum TNF-α levels are positively correlated with the course of diabetic nephropathy, and the possible mechanism is that TNF-α damages diabetic glomerular tissue by producing inflammatory response cytokines and increasing microvascular permeability [29]. The PI3K-AKT [38] signaling pathway is the main pathway associated with insulin signal transduction, which can regulate glucose homeostasis and lipid metabolism by mediating the production of growth factors. Inhibition of this pathway can lead to insulin resistance and subsequently suppress T2DM [39]. Apple pollen can exert a role in treating T2DM by intervening in the above pathways. For example, quercetin can lower blood glucose in T2DM rats by reducing the level of oxidative stress, which can also effectively inhibit TNF in vascular smooth muscle cells-α and monocyte chemoattractant protein-1 (MCP-1).

Altogether 28 compounds were successfully identified in Qinguan pollen and Gala apple pollen, including flavonoids and organic acids. Among them, 17 compounds were identified for the first time in apple pollen, while the other 9 were previously reported [25].

From the obtained total ion chromatograms of Qinguan pollen and Gala apple pollen, it was found that a few of chromatogram peaks did not match with the corresponding compounds, indicating the presence of some unknown chemical compositions in apple pollen, which should be further investigated.

5. Conclusions

To conclude, different from chemical drugs, TCM is a multi-component and complex drug. Thus, it is challenging to pinpoint the mech-anisms of action of TCM. Each herb may contain many active ingredients that have single or multiple targets. As a result, it is difficult to pinpoint the mechanisms of action of TCM. However, in the traditional research of network pharmacology, the compounds are mostly collected from databases. Besides, some compounds cannot be detected in some TCM, which may yield false positive results.

In this study, we use HPLC-Q-TOF-MS/MS based on multiple in-house chemical libraries coupled with network pharmacology, which was utilized to characterize the chemical compounds of apple pollen and investigate its underlying mechanism in treating T2DM.

A total of 2 compounds were identified in apple pollen, among which, 20 were considered as the potential compounds. Apart from that, a total of 510 targets were predicted, and AKT1, PPARG, EGFR, SRC, ESR1 and MAPK1 were recognized as the main potential targets involved in T2DM [40, 41]. Moreover, insulin resistance, hepatitis C, pancreatic cancer, TNF signaling pathway, insulin signaling pathway, and PI3K-AKT signaling pathway were the mechanisms by which apple pollen exerted its therapeutic effect on T2DM [38].

The above results reduce the prediction range and increase the accuracy of the prediction results, also providing important information for performing further pharmacological investigations on apple pollen.

Data Availability

The data used to support the findings of this study are included within the article.

Conflicts of Interest

The authors declare that they have no conflicts of interest.

Acknowledgments

Xi'an Science and Technology Planning Project-Development of Breathing Apparatus with Traditional Chinese Medicine on COVID-19 (20YXYJ0012(11)). Financial support institution: Shaanxi Academy of Traditional Chinese Medicine, Shaanxi, China, VAT Reg No: 12610000435200693H.

References

L. Zhang, X. Wang, X. Gu, P. Zhang, Z.-J. Lu, and Y. Xu, “Integrated therapy of traditional Chinese and western medicine for BPH with diabetes mellitus: clinical observation of 52 cases,” National Journal of Andrology, vol. 17, no. 6, pp. 568–570, 2011.
View at: Google Scholar
X.-P. Zhang, X.-Z. Zhou, H.-K. Huang, Q. Feng, S.-B. Chen, and B.-Y. Liu, “Topic model for Chinese medicine diagnosis and prescription regularities analysis: case on diabetes,” Chinese Journal of Integrative Medicine, vol. 17, no. 4, pp. 307–313, 2011.
View at: Publisher Site | Google Scholar
Q. H. Dai and Z. D. Wang, “Survey of the status of diabetes in China,” China Medical Guide, vol. 9, no. 13, p. 206, 2011.
View at: Google Scholar
K. Zhou, F. Yang, N. Yao, Z. Quan, and M. Shan, “Nutrition and function of pollen,” Journal of Agricultural Products Processing, vol. 19, pp. 60–63, 2013.
View at: Google Scholar
“Guideline for prevention and treatment of type 2 diabetes in China (2017 edition),” Chinese Journal of Practical Internal Medicine, vol. 38, no. 4, pp. 292–344, 2018.
View at: Google Scholar
Z. Z. Qu, Y. H. Wang, and J. L. Wang, “A study on nutritional compositions in pollens of several species of fruit trees,” Journal of Agricultural University of Hebei, vol. 12, no. 4, p. 66, 1989.
View at: Google Scholar
H. D. Xu and Q. G. Luo, “On the development and utilization of fruit and flower resources in China,” China Fruit Research, vol. 3, pp. 19-20, 1995.
View at: Google Scholar
X. Y. Yang, S. L. Yang, and H. Yang, “Research progress on utilization of pollen resources,” Special Wild Economic Animal and Plant Research, vol. 4, pp. 52–56, 2003.
View at: Google Scholar
K. F. Wang, “Pollen resources in China are very rich and need to be vigorously developed and utilized,” Applied Technology, vol. 1, p. 37, 1997.
View at: Google Scholar
K. F. Wang, “Review on research progress of pollen medicine,” World Science and Technology, vol. 2, no. 2, pp. 51–53, 2000.
View at: Google Scholar
H. Chahdoura, J. C. M. Barreira, L. Barros, C. Santos-Buelga, I. C. F. R. Ferreira, and L. Achour, “Phytochemical characterization and antioxidant activity of the cladodes of opuntia macrorhiza (engelm.) and opuntia microdasys (lehm.),” Food & Function, vol. 5, no. 9, pp. 2129–2136, 2014.
View at: Publisher Site | Google Scholar
E. Furusawa, S. C. Chou, A. Hirazumi, and A. Melera, “Antitumour potential of pollen extract on lewis lung carcinoma implanted intraperitoneally in syngeneic mice,” Phytotherapy Research, vol. 9, no. 4, pp. 255–259, 1995.
View at: Publisher Site | Google Scholar
J. Li, “Pharmacological and effective components of pollen,” Chinese Pharmaceutical, vol. 25, pp. 259–262, 1990.
View at: Google Scholar
K. F. Wang, “Review on research progress of pollen medicine,” World Science and Technology/Modernization of Traditional Chinese Medicine, vol. 2, pp. 51–53, 2000.
View at: Google Scholar
X. L. Zhou, “Study on pharmacological action and application of pollen,” Heilongjiang Medicine Journal, vol. 2, no. 2, pp. 152–155, 2009.
View at: Google Scholar
X. L. Wang, “Edible medicinal value and development prospect of pollen,” Journal of Anhui Agricultural Sciences, vol. 35, pp. 6233-6234, 2007.
View at: Google Scholar
Y. H. Li, X. Y. Lv, and F. L. Hu, “Trend and statusquo of research on pollen components,” Chinese Journal of Modern Applied Pharmacy, vol. 23, pp. 613–615, 2006.
View at: Google Scholar
M. J. Zhang, P. Zhu, and D. Li, “Identification of isorhmnetin and chlorogenic acid and determination of total flavonoids in apple pollen,” Chinese Journal of Pharmaceutical Analysis, vol. 36, no. 4, pp. 617–623, 2016.
View at: Google Scholar
Y. Ling, Z. Fu, Q. Zhang, L. Xu, and L. Liao, “Identification and structural elucidation of steroidal saponins from the root of Paris polyphyllaby HPLC-ESI-QTOF-MS/MS,” Natural Product Research, vol. 29, no. 19, pp. 1798–1803, 2015.
View at: Publisher Site | Google Scholar
J. Yuan, J. Hu, D. Wang, M. Gong, and P. Li, “Analysis of main active components in leaves and flowers of Forsythia suspensa from different regions,” Natural Product Research and Development, vol. 32, no. 3, pp. 389–397, 2020.
View at: Google Scholar
D. Huang, B. T. Sherman, and R. A. Lempicki, “Swiss target prediction: updated data and new features for efficient prediction of protein targets of small molecules,” Nucleic Acids Research, vol. 47, no. 2, pp. 357–364, 2019.
View at: Google Scholar
D. W. Huang, B. T. Sherman, and R. A. Lempicki, “Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources,” Nature Protocols, vol. 4, no. 1, pp. 44–57, 2009.
View at: Publisher Site | Google Scholar
D. Huang, B. T. Sherman, and R. A. Lempicki, “Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists,” Nucleic Acids Research, vol. 37, no. 1, pp. 1–13, 2009.
View at: Publisher Site | Google Scholar
D.-F. S. Ricardo and Q. B. Cass, “Characterization of four phyllanthus species using liquid chromatography coupled to tandem mass spectrometry,” Journal of Chromatography A, vol. 1291, pp. 97–103, 2013.
View at: Google Scholar
S. Kumar, A. Singh, and V. Bajpai, “Structural characterization of monoterpene indole alkaloids in ethanolic extracts of rauwolfia species by liquid chromatography with quadrupole time-of-flight mass spectrometry,” Journal of Phytochemical Analysis, vol. 6, no. 6, pp. 363–373, 2016.
View at: Publisher Site | Google Scholar
J. Wang, H. Chu, H. Li et al., “A network pharmacology approach to investigate the mechanism of erjing prescription in type 2 diabetes,” Evidence-Based Complementary and Alternative Medicine, vol. 2021, Article ID 9933236, 13 pages, 2021.
View at: Publisher Site | Google Scholar
L. Jiang, Z. Shi, and Y. Yang, “Network pharmacology-based approach to investigate the molecular targets of rhubarb for treating cancer,” Evidence-Based Complementary and Alternative Medicine, vol. 2021, Article ID 9945633, 8 pages, 2021.
View at: Publisher Site | Google Scholar
F. Luo, “The application of LC-MS technology in traditional Chinese medicine analysis,” Asia-Pacific Traditional Medicine, vol. 10, pp. 52–54, 2014.
View at: Google Scholar
L. Wang, X. Wang, and H. Zhong, “Analysis of flavonoids in robinia pseudoacacia L. flowers by HPLC-MS,” Food and Drug, vol. 15, no. 4, pp. 240–242, 2013.
View at: Google Scholar
K. Susan, S. Hiroyuki, and Z. W. Liu, “A method to identify serine kinase substrates: Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain,” Journal of Biological Chemistry, vol. 277, no. 25, pp. 22115–22118, 2002.
View at: Google Scholar
R. Mukherjee, L. Jow, G. E. Croston, and J. R. Paterniti, “Identification, characterization, and tissue distribution of human peroxisome proliferator-activated receptor (PPAR) isoforms PPARγ2 versus PPARγ1 and activation with retinoid X receptor agonists and antagonists,” Journal of Biological Chemistry, vol. 272, no. 12, pp. 8071–8076, 1997.
View at: Publisher Site | Google Scholar
H. Y. Zhang, “Prevalence and related factors of type 2 diabetes mellitus in patients with chronic hepatitis B,” China Health Industry, vol. 11, no. 33, pp. 56-57, 2014.
View at: Google Scholar
P. Li and M. R. Wang, “Correlation between hepatitis C virus infection and type 2 diabetes mellitus,” Journal of Practical Hepatology, vol. 19, no. 2, pp. 253–256, 2016.
View at: Google Scholar
C. M. Girgis, K. Cheng, C. H. Scott, and J. E. Gunton, “Novel links between HIFs, type 2 diabetes, and metabolic syndrome,” Trends in Endocrinology and Metabolism, vol. 23, no. 8, pp. 372–380, 2012.
View at: Publisher Site | Google Scholar
M. Croft, C. A. Benedict, and C. F. Ware, “Clinical targeting of the TNF and TNFR superfamilies,” Nature Reviews Drug Discovery, vol. 12, no. 2, pp. 147–168, 2013.
View at: Publisher Site | Google Scholar
M.-F. Hivert, L. M. Sullivan, C. S. Fox et al., “Associations of adiponectin, resistin, and tumor necrosis factor-α with insulin resistance,” Journal of Clinical Endocrinology & Metabolism, vol. 93, no. 8, pp. 3165–3172, 2008.
View at: Publisher Site | Google Scholar
A. Gratas-Delamarche, F. Derbré, S. Vincent, and J. Cillard, “Physical inactivity, insulin resistance, and the oxidative-inflammatory loop,” Free Radical Research, vol. 48, no. 1, pp. 93–108, 2014.
View at: Publisher Site | Google Scholar
S. Bathina and U. N. Das, “Dysregulation of PI3K-Akt-mTOR pathway in brain of streptozotocin-induced type 2 diabetes mellitus in wistar rats,” Lipids in Health and Disease, vol. 17, no. 1, p. 168, 2018.
View at: Publisher Site | Google Scholar
B. Li, Y. Fan, and X. Li, “Research progress of traditional Chinese medicine in the treatment of insulin resistance in type 2 diabetes mellitus based on PI3K/Akt signaling pathway,” Chinese Patent Medicine, vol. 39, no. 1, pp. 151–154, 2017.
View at: Google Scholar
C. S. Cui, Y. Zhang, J. Y. Zhao et al., “Research on the mechanism of combination of polygonatum sibiricum and codonopsis pilosula in the treatment of type 2 diabetes based on network pharmacology,” Shi Zhen Guo Yi Guo Yao, vol. 31, no. 3, pp. 571–575, 2020.
View at: Google Scholar
Z. L. Song and Y. K. Lin, “Based on network pharmacology study on the mechanism of six wei dihuang pill in intervention of type two diabetes mellitus,” China Pharmacist, vol. 23, no. 11, pp. 2151–2155, 2020.
View at: Google Scholar

Copyright

Copyright © 2022 Yiwen Wang and Ping Chen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation

Download other formats

Order printed copies

Views

363

Downloads

583

Citations